Mednet Logo
CommunityMedical Oncology

What is your preferred up-front treatment for transplant-eligible patients with primary (de novo) plasma cell leukemia?

Community PollStarted

What is your preferred induction therapy for transplant-eligible patients with primary plasma cell leukemia?

23 physicians have voted

Join Mednetto vote and see how they answered.

2 Answers
Mednet Member
Mednet MemberInvited Expert
Medical Oncology · University of Chicago
Answered on

To some extent, it really will depend on how aggressively the disease is behaving. Most PCL cases are quite aggressive and need urgent therapy. For an extremely fit individual who is usually in the inpatient setting, I opt for VD-PACE (usually the IMiD is not available quickly). I will perform a TTE...

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Medical Oncology · University of Washington, Fred Hutchinson Cancer Research Center
Answered on

Agreed with @Dr. First Last on all fronts, including considering Dara-KRd after a cycle of inpatient chemo-based induction... and venetoclax with t(11;14) for any relapse or refractoriness. We had initially been a bit apprehensive that venetoclax would interfere with stem cell collection, but so far...

Join for free or sign in to see the full answer